Navigation Links
Abbott to Present New Data Across its Vascular Portfolio at the,,,American College of Cardiology's 56th Annual Scientific Session

p>

EXACT and CAPTURE 2 Carotid Clinical Trial 30-Day Results

Late-Breaking Clinical Trials III, i2. Summit Interventional Programming Monday, March 26, 11:15 a.m. Central Time

Room La Nouvelle Orleans C, Ernest N. Morial Convention Center

Interim results of 30-day clinical follow-up for the first 1,500 patients enrolled in Abbott's EXACT clinical study and the first 600 patients enrolled in CAPTURE 2 will be presented by William A. Gray, M.D., FACC, from the Medical Center in New York. EXACT and CAPTURE 2 are studies designed to confirm that carotid stenting can be performed with good results by a variety of physician specialties in real-world (non-clinical trial) settings in patients who are at high risk for carotid artery surgery. Clinical outcome data for Abbott's Emboshield BareWire(TM) Rapid Exchange Embolic Protection System and Xact Rapid Exchange Carotid Stent System and ACCULINK(TM) Carotid Stent System and ACCUNET(TM) Embolic Protection System will be reported.

Late-Breaking Clinical Trials III Press Conference at ACC

EXACT and CAPTURE 2 data will be included in the ACC late-breaking clinical trials III press conference at noon Central time on Monday, March 26, in Press Conference Room 215.

SPIRIT II One Year Clinical Results with 300 Patients

e-Poster Session 210 - Monday, March 26, 2 p.m. Central Time

Hall H, Ernest N. Morial Convention Center

One-year follow-up results from 300 patients in the SPIRIT II clinical trial will be presented in a poster session by Peter Ruygrok, M.D., cardiologist at Auckland City Hospital and Clinical Associate Professor at University of Auckland, New Zealand. This is the first time that long-term data will be presented from SPIRIT II, a 300-patient, randomized, single- blind, prospective clinical trial evaluating XIENCE V versus TAXUS in Europe and Asia Pacific. In addition, Abbott will also pres
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. The Past, Present and Future of HLA Typing
11. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:8/19/2014)... Avizia, Inc., a leading provider of cutting-edge ... equity financing round led by NextGen Angels along with ... will be used to continue to fuel the rapidly ... Edward Kennedy , CEO and president of Tollgrade ... Leonard Kurtzman , CFO of newBrandAnalytics, who joined the ...
(Date:8/19/2014)... MALVERN, Pa. , Aug. 19, 2014  SCILEX ... commercialization of late-stage pharmaceutical products for the treatment of ... composed of four members: Dr. Jeff Gudin , ... and Mr. Kip Vought . ... said the expertise of this board would greatly assist ...
(Date:8/19/2014)... Aug. 19, 2014 Luoxis Diagnostics, ... Inc. (NYSE MKT: AMPE), today announced an ... Meeting of the American Academy of Surgical Trauma ... in Philadelphia, Pennsylvania that ... will report results from a recently completed five-year ...
Breaking Medicine Technology:Avizia Closes Funding Round 2SCILEX Pharmaceuticals Announces Scientific Advisory Board 2SCILEX Pharmaceuticals Announces Scientific Advisory Board 3SCILEX Pharmaceuticals Announces Scientific Advisory Board 4Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3
... Calif., Dec. 21 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... payment from OncoGenex Pharmaceuticals, Inc. (Nasdaq: OGXI ) ... Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation ... a successful Phase 2 program in patients with advanced prostate ...
... , SAN DIEGO, Dec. 18 LifeVantage Corporation ... Anti-Aging Cream, science-based solutions to oxidative stress, announced today that ... other parties, Zrii, LLC. Under the terms of this agreement, ... William Farley, on the one hand, and the Company and ...
Cached Medicine Technology:Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 2Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 3LifeVantage Announces Settlement of Zrii Litigation 2LifeVantage Announces Settlement of Zrii Litigation 3
(Date:8/20/2014)... This agreement will allow storageFOUNDRY ... networking, high availability cloud enablement, service, and elastic ... allowing OPEN-V to sell storageFOUNDRY’s expanding Nautilus line ... with OPEN-V on this distribution agreement of our ... channels at storageFOUNDRY. "Nautilus is a massively scalable, ...
(Date:8/19/2014)... well-known bamboo product manufacturer and retailer, has unveiled its new ... excited to reveal the new items, and it has decided ... every customer can get a discounted price, up to 30 ... , The company’s deckings are made of the finest quality, ... are perfect for a dining room, living room, kitchen, foyer, ...
(Date:8/19/2014)... Crosley Law Firm, PC has reached a confidential ... Star Bakery for an undisclosed amount. The two claimants, Pete ... of 2011, respectively. The injuries were caused by two different ... to the left hand of each man. , At the ... short-staffed, having lost 200 of its, 500 workers in connection ...
(Date:8/19/2014)... an outstanding company in the garment industry, has unveiled its ... to this, the company has also launched a big sale ... at low rates, up to 30 percent off. , ... bohemian outfits are available in many colours, including green, blush, ... quality clothes, reasonable prices and sincere service, the company has ...
(Date:8/19/2014)... the brain involved in multitasking and ways to train ... the IUGM Institut universitaire de griatrie de Montral and ... to better predict the effectiveness of this training. Cooking ... the Web, or driving while listening to a radio ... our daily lives. Unfortunately, it decreases with age, which ...
Breaking Medicine News(10 mins):Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 3Health News:Promotional Bamboo Deckings from Well-known Online Supplier BambooIndustry.com 2Health News:Crosley Law Firm Reaches Settlement for Hand Amputation Victims at Commercial Bakery 2Health News:2014 Bohemian Dresses Now for Sale at Skmen.com 2Health News:Targeted brain training may help you multitask better 2
... have found out why women who have a baby when ... breast cancer. They have identified a substance produced naturally in ... pregnancy trigger the changes in the breast tissue of young ... a pill that could protect against breast cancer. ...
... franchisee for US based Medicine Shoppe International, with operations in ... list of its target for operations in the country. According ... expand its franchisee operations from the present 19 outlets to ... decided to put on hold the commencing of operations in ...
... Common childhood vaccinations, including newer ones such as those ... diabetes. The conclusion came from a look at 768 ... had juvenile diabetes. Those who had been vaccinated against ... no more likely to have developed diabetes than those ...
... hormone production may help explain why obese people who carry ... a high risk of heart disease and other health problems. ... and its complications. // ,It is no news ... heart disease and diabetes, but where these extra pounds accumulate ...
... some time that a wide range of influenza viruses circulate in ... humans. These are two subtypes of the influenza A virus known ... was reported in Hong Kong in mid-May . ,The ... six people and infect 12 others in a small but densely ...
... may not only an effective treatment for malaria, the ... be similar to the mechanism they use to ... these findings at the 50th Annual Meeting of the ... ,The compounds called disulfides, occur naturally in garlic, ...
Cached Medicine News:
IBT Reference Laboratory is a national research and specialty clinical lab founded in 1983 that provides a wide range of tests and services in the area of allergy, clinical immunology and molecular b...
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...
the LabOne Healthcare Group markets laboratory testing to physicians, patients, managed care companies, self-insured employers, wellness companies and hospitals....
Medicine Products: